Live Price
Live Volume
Chart Volume 0
Volume 0
5 secAgios Pharmaceuticals Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $33.61 |
|---|---|
| Close | $33.61 |
| Low | $33.61 |
| Low Change | 0.00 (0.00%) |
| High | $33.61 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 155.862K |
| Dollar Volume | $5.24M |
Regular Trading Hours Yesterday
+0.19(+0.55%)
| Open | $33.42 |
|---|---|
| Close | $33.61 |
| Low | $33.19 |
| Low Change | -0.23 (-0.69%) |
| High | $34.30 |
| High Change | +0.88 (+2.62%) |
| Range | $1.11 |
| Volume | 379.027K |
| Dollar Volume | $12.74M |
Premarket Yesterday
+0.55(+1.67%)
| Open | $32.90 |
|---|---|
| Close | $33.45 |
| Low | $32.90 |
| Low Change | 0.00 (0.00%) |
| High | $33.50 |
| High Change | +0.60 (+1.82%) |
| Range | $0.60 |
| Volume | 2.187K |
| Dollar Volume | $73.16K |
Agios Pharmaceuticals News
2 months agoinvesting.comAgios Pharmaceuticals stock falls on trial update
- 4 months agoinvesting.com
Agios Pharmaceuticals stock tumbles on trial setback
- 5 months agoinvesting.com
Agios Pharmaceuticals stock tumbles 25% after Novo data
- 9 months agoinvesting.com
Agios Pharmaceuticals stock soars after FDA approves AQVESME for thalassemia
- 9 months agoinvesting.com
Agios Pharmaceuticals secures FDA approval for thalassemia treatment
Agios Pharmaceuticals Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Agios Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $33.24 |
|---|---|
| 10 Day Moving Average (SMA10) | $33.42 |
| 20 Day Moving Average (SMA20) | $33.56 |
| 50 Day Moving Average (SMA50) | $34.77 |
| 100 Day Moving Average (SMA100) | $32.77 |
| 200 Day Moving Average (SMA200) | $30.69 |
Agios Pharmaceuticals Statistics
| Average Volume (30 Days) | 925.41K |
|---|---|
| P/E Ratio (Current) | -4.78 |
| EPS (Current) | -$6.89 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$365.25M |
| Cash Ratio | 1.42 |
| Current Ratio | 10.22 |
| Quick Ratio | 9.79 |
| Debt to Equity | 0.00 |
| Enterprise Value | $1.87B |
| EV to EBITDA | -4.12 |
| EV to Sales | 18.99 |
| Price to Book | 1.92 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 20.00 |
| Return on Assets | -0.37% |
| Return on Equity | -0.40% |
Agios Pharmaceuticals Stock Splits
There have been no stock splits for Agios Pharmaceuticals (AGIO).
Agios Pharmaceuticals Dividends
There have been no dividends for Agios Pharmaceuticals (AGIO).